Development of Dihydroquercetin-based Oral tablets and Evalution of the General Toxic Effect

Development of Dihydroquercetin-based Oral tablets and Evalution of the General Toxic Effect

Introduction. Dihydroquercetin is a flavonoid from the group of flavanonols with a wide spectrum of pharmacological activity. Its positive therapeutic profile was established for chronic venous insufficiency, chronic obstructive pulmonary disease and bronchial asthma, for the prevention of stroke. I...

Full description

Bibliographic Details
Main Authors: S. A. Abdulrazzak, A. N. Vorobyev, N. I. Sinitsyna, I. V. Sharutin, O. V. Menshova, E. V. Elizarova, Yu. V. Ivanov, A. S. Karamyan, R. A. Abramovich, O. G. Potanina, K. M. Sakanyan
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2022-05-01
Series:Разработка и регистрация лекарственных средств
Subjects:
таблетки
дигидрокверцетин
прямое прессование
вспомогательные вещества
вэжх-уф
острая токсичность
многократное введение
местно-раздражающее действие
Online Access:https://www.pharmjournal.ru/jour/article/view/1226

Internet

https://www.pharmjournal.ru/jour/article/view/1226

Similar Items